Download PDF
Zeitschrift für Phytotherapie 2013; 34(06): 280-283
DOI: 10.1055/s-0033-1349776
Praxis
Atemwege
© Haug Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG

Phytotherapie bei Atemwegserkrankungen

Was empfehlen die aktuellen medizinischen Leitlinien?
Karin Kraft
Subject Editor:
Further Information

Publication History

Publication Date:
07 January 2014 (online)

    Permissions and Reprints

Zusammenfassung

Von den 29 Leitlinien der AWMF, die sich mit Erkrankungen der Atemwege befassen, finden sich in 3 Leitlinien konkrete Hinweise auf pflanzliche Drogen bzw. Arzneimittel, in denen insgesamt 12 klinische Studien sowie 2 Metaanalysen kurz kommentiert werden. Zudem werden einige weitere weniger gut klinisch geprüfte pflanzliche Drogen hinsichtlich ihrer Wirkungen und möglichen Applikationsformen tabellarisch aufgeführt. Die Empfehlungsgrade zur Anwendung pflanzlicher Drogen sind in diesen Leitlinien im Allgemeinen zurückhaltend formuliert.

Summary

Phytotherapy and respiratory diseases. What do German medicinal guidelines recommend?

Out of the 29 medicinal guidelines of the AWMF on diseases of the respiratory tract, only three mention medicinal herbal drugs or herbal medicinal products. Regarding these guidelines, a total of 12 clinical studies and two meta-analyses on herbal medicinal products are shortly commented upon. Moreover, the effects and possible application forms of various medicinal herbal drugs with lower evidence are shown in tables. In general, the degree of recommendation of the herbal medicinal products is considerably restrictive.

Schlüsselwörter

Medizinische Leitlinien - Phytotherapie - Atemwegserkrankungen

Key words

Medicinal guidelines - herbal medicine - respiratory diseases
 

  • Literatur

  • 1 Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e.V. (AWMF). http://www.awmf.org/leitlinien/aktuelle-leitlinien.html
    PubMed
  • 2 Bachert C, Schapowal A, Funk P et al. Treatment of acute rhinosinusitis with the preparation from Pelargonium sidoides EPs 7630: a randomized, double-blind, placebo-controlled trial. Rhinology 2009; 47: 51-58
    PubMedGoogle Scholar
  • 3 Bereznoy VV, Riley DS, Wassmer G, Heger M. Efficacy of extract of Pelargonium sidoides in children with acute non-group A betahemolytic streptococcus tonsillopharyngitis: a randomized, double-blind, placebo-controlled trial. Altern Ther Health Med 2003; 9: 68-79
    Google Scholar
  • 4 Blumenröder WO. Angina lacunaris. Z Allgemeinmed 1985; 61: 271-273
    PubMedGoogle Scholar
  • 5 Braun JM, Schneider B, Beuth HJ. Therapeutic use, efficiency and safety of the proteolytic pineapple enzyme Bromelain-POS in children with acute sinusitis in Germany. In Vivo 2005; 19: 417-421
    PubMedGoogle Scholar
  • 6 Federspil P, Wulkow R, Zimmermann T. Wirkung von Myrtol standardisiert bei der Therapie der akuten Sinusitis – Ergebnisse einer doppelblinden, randomisierten Multicenterstudie gegen Plazebo. Laryngorhinootologie 1997; 76: 23-27
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Hubbert M, Sievers H, Lehnfeld R et al. Efficacy and tolerability of a spray with Salvia officinalis in the treatment of acute pharyngitis – a randomised, double-blind, placebo-controlled study with adaptive design and interim analysis. Eur J Med Res 2006; 11: 20-26
    PubMedGoogle Scholar
  • 8 Huntley AL, Thompson Coon J, Ernst E. The safety of herbal medicinal products derived from Echinacea species: a systematic review. Drug Saf 2005; 28: 387-400
    CrossrefPubMedGoogle Scholar
  • 9 Kehrl W, Sonnemann U, Dethlefsen U. Therapy for acute nonpurulent rhinosinusitis with cineole: results of a double-blind, randomized, placebo-controlled trial. Laryngoscope 2004; 114: 738-742
    CrossrefPubMedGoogle Scholar
  • 10 Kemmerich B. Evaluation of efficacy and tolerability of a fixed combination of dry extracts of thyme herb and primrose root in adults suffering from acute bronchitis with productive cough. A prospective, doubleblind, placebo-controlled multicentre clinical trial. Arzneimittelforschung 2007; 57: 607-615
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Kemmerich B, Eberhardt R, Stammer H. Efficacy and tolerability of a fluid extract combination of thyme herb and ivy leaves and matched placebo in adults suffering from acute bronchitis with productive cough. A prospective, double-blind, placeplacebo-controlled clinical trial. Arzneimittelforschung 2006; 56: 652-660
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Lasek R, de Smet PAGM. UAW von Phythopharmaka. In: Müller-Oerlinghausen B, Lasek R, Düppenbecker H, Munter KH, Hrsg. Handbuch der unerwünschten Arzneimittelwirkungen München: Urban & Fischer; 1996
    Google Scholar
  • 13 Linde K, Barrett B, Wölkart K et al. Echinacea for preventing and treating the common cold. Cochrane Database Syst Rev 2006; CD000530
    PubMedGoogle Scholar
  • 14 Melchart D, Linde K, Fischer P et al. Echinacea for preventing and treating the common cold. Cochrane Database Syst Rev 2000; CD000530
    PubMedGoogle Scholar
  • 15 Neubauer N, März R. Placebo-controlled, randomized double-blind clinical trial with Sinupret sugar-coated tablets on the basis of a therapy with antibiotics and decongestant nasal drops in acute sinusitis. Phytomedicine 1994; 1: 177-181
    CrossrefPubMedGoogle Scholar
  • 16 Seltzer AP. Adjunctive use of bromelains in sinusitis: a controlled study. Eye Ear Nose Throat Mon 1967; 46: 1281-1288
    PubMedGoogle Scholar
  • 17 Shah SA, Sander S, White CM et al. Evaluation of echinacea for the prevention and treatment of the common cold: a metaanalysis. Lancet Infect Dis 2007; 7: 473-480
    CrossrefPubMedGoogle Scholar
  • 18 Taub SJ. The use of bromelains in sinusitis: a double-blind clinical evaluation. Eye Ear Nose Throat Mon 1967; 46: 361-362
    PubMedGoogle Scholar
  • 19 Tesche S, Metternich F, Sonnemann U et al. The value of herbal medicines in the treatment of acute non-purulent rhinosinusitis. Results of a double-blind, randomised, controlled trial. Eur Arch Otorhinolaryngol 2008; 265: 1355-1359
    CrossrefPubMedGoogle Scholar